Do you need help to identify participating investigators/clinics for a clinical study? Submit your Site Feasibility to the regional node of the healthcare region of interest. If you want to extend your feasibility to additional healthcare regions, then send your Site Feasibility to more than one regional node. You can find contact information for all regional nodes within Clinical Studies Sweden at the right hand side of the page.
Please include as much information as possible. Company-specific Confidentiality Disclosure Agreements (CDAs) will not be set up at this stage. You can make reference to the confidentiality legislation governing health and medical care, see the Swedish Association of the Pharmaceutical Industry (LIF) statement on confidentiality in relation to public agencies according to SFS 2009:400 and a temple for a standard text for reference.
Please include the following information in your request:
- Therapeutic area and primary purpose of the trial
- Trial phase (I-IV)
- Trial substance/drug/product or equivalent
- Inclusion and exclusion criteria
- Suggested clinics and any requirements for specialist training and/or equipment
- Time and enrolment plan
- Name of site or investigator (if a request already has been sent)
- Deadline for response by interested clinics
- Contact person and contact details of sponsor
- Whether Sweden has been selected to participate
Please write ”Site Feasibility” in the subject line. The feasibility request will be distributed to the network of experienced investigators within the healthcare region(s). The regional node(s) within Clinical Studies Sweden will respond as soon as possible. If needed, we may ask for additional information or clarification related to the feasibility before it is sent to the investigators. Contact information for the regional nodes within Clinical Studies Sweden are shown at the right hand side of the page.
Clinical Studies Sweden is a collaboration between Sweden’s six healthcare
regions, funded and supported by the Swedish Research Council. The
collaboration aims to simplify and develop the work of clinical studies.